{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:33:48Z","timestamp":1755225228700,"version":"3.43.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,13]]},"DOI":"10.7759\/cureus.89956","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T08:04:48Z","timestamp":1755072288000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unusual Case of Primary Sj\u00f6gren\u2019s Syndrome and Lymphangioleiomyomatosis Diagnosed From Refractory Cough"],"prefix":"10.7759","author":[{"given":"Ruo-Nan","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts","volume":"69","author":"Shiboski CH","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al.. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017, 69:35-45. 10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-63046-1_12","article-title":"Sjogren's Syndrome and Pulmonary Disease","volume":"1303","author":"Peredo RA","year":"2021","unstructured":"Peredo RA, Beegle S. Sjogren's Syndrome and Pulmonary Disease. Adv Exp Med Biol. 2021, 1303:193-207. 10.1007\/978-3-030-63046-1_12","journal-title":"Adv Exp Med Biol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S47399","article-title":"The epidemiology of Sj\u00f6gren's syndrome","volume":"6","author":"Patel R","year":"2014","unstructured":"Patel R, Shahane A. The epidemiology of Sj\u00f6gren's syndrome. Clin Epidemiol. 2014, 6:247-55. 10.2147\/CLEP.S47399","journal-title":"Clin Epidemiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3601-1","article-title":"Prevalence and characterization of non-sicca onset primary Sj\u00f6gren syndrome with interstitial lung involvement","volume":"36","author":"Manfredi A","year":"2017","unstructured":"Manfredi A, Sebastiani M, Cerri S, et al.. Prevalence and characterization of non-sicca onset primary Sj\u00f6gren syndrome with interstitial lung involvement. Clin Rheumatol. 2017, 36:1261-8. 10.1007\/s10067-017-3601-1","journal-title":"Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","volume":"9","author":"McCarthy C","year":"2021","unstructured":"McCarthy C, Gupta N, Johnson SR, et al.. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet Respir Med. 2021, 9:1313-1327. 10.1016\/S2213-2600(21)00228-9","journal-title":"Lancet Respir Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-00932-6","article-title":"Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies","volume":"19","author":"Thorlacius GE","year":"2023","unstructured":"Thorlacius GE, Bj\u00f6rk A, Wahren-Herlenius M. Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies. Nat Rev Rheumatol. 2023, 19:288-306. 10.1038\/s41584-023-00932-6","journal-title":"Nat Rev Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0021-2020","article-title":"Lung complications of Sjogren syndrome","volume":"29","author":"Luppi F","year":"2020","unstructured":"Luppi F, Sebastiani M, Sverzellati N, Cavazza A, Salvarani C, Manfredi A. Lung complications of Sjogren syndrome. Eur Respir Rev. 2020, 29:10.1183\/16000617.0021-2020","journal-title":"Eur Respir Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1702195","article-title":"Lymphangioleiomyomatosis","volume":"41","author":"Xu KF","year":"2020","unstructured":"Xu KF, Xu W, Liu S, et al.. Lymphangioleiomyomatosis. Semin Respir Crit Care Med. 2020, 41:256-68. 10.1055\/s-0040-1702195","journal-title":"Semin Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03834-w","article-title":"Increased malignancy risk in patients with lymphangioleiomyomatosis: findings from a Chinese cohort","volume":"20","author":"Zhang X","year":"2025","unstructured":"Zhang X, Cheng C, Wang H, et al.. Increased malignancy risk in patients with lymphangioleiomyomatosis: findings from a Chinese cohort. Orphanet J Rare Dis. 2025, 20:263. 10.1186\/s13023-025-03834-w","journal-title":"Orphanet J Rare Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren's syndrome","volume":"45","author":"Lessard CJ","year":"2013","unstructured":"Lessard CJ, Li H, Adrianto I, et al.. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren's syndrome. Nat Genet. 2013, 45:1284-92. 10.1038\/ng.2792","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.998028","article-title":"Radiological patterns and pulmonary function values of lung involvement in primary Sj\u00f6gren's syndrome: A pilot analysis","volume":"9","author":"Mormile I","year":"2022","unstructured":"Mormile I, Mormile M, Rossi FW, et al.. Radiological patterns and pulmonary function values of lung involvement in primary Sj\u00f6gren's syndrome: A pilot analysis. Front Med (Lausanne). 2022, 9:998028. 10.3389\/fmed.2022.998028","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management","volume":"194","author":"McCormack FX","year":"2016","unstructured":"McCormack FX, Gupta N, Finlay GR, et al.. Official American Thoracic Society\/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management. Am J Respir Crit Care Med. 2016, 194:748-61. 10.1164\/rccm.201607-1384ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-1976-1","article-title":"Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1\/2 signaling pathway in normal and neoplastic B-lymphoid cells","volume":"72","author":"Zeng Q","year":"2015","unstructured":"Zeng Q, Zhang H, Qin J, et al.. Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1\/2 signaling pathway in normal and neoplastic B-lymphoid cells. Cell Mol Life Sci. 2015, 72:4867-84. 10.1007\/s00018-015-1976-1","journal-title":"Cell Mol Life Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0933-0","article-title":"Comorbid connective tissue diseases and autoantibodies in lymphangioleiomyomatosis: a retrospective cohort study","volume":"13","author":"Futami S","year":"2018","unstructured":"Futami S, Arai T, Hirose M, et al.. Comorbid connective tissue diseases and autoantibodies in lymphangioleiomyomatosis: a retrospective cohort study. Orphanet J Rare Dis. 2018, 13:182. 10.1186\/s13023-018-0933-0","journal-title":"Orphanet J Rare Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03109-4","article-title":"Iguratimod suppresses Tfh cell differentiation in primary Sj\u00f6gren's syndrome patients through inhibiting Akt\/mTOR\/STAT3 signaling","volume":"25","author":"Lyu T","year":"2023","unstructured":"Lyu T, Jiang H, Zeng L, et al.. Iguratimod suppresses Tfh cell differentiation in primary Sj\u00f6gren's syndrome patients through inhibiting Akt\/mTOR\/STAT3 signaling. Arthritis Res Ther. 2023, 25:152. 10.1186\/s13075-023-03109-4","journal-title":"Arthritis Res Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.01.028","article-title":"Diffuse Cystic Lung Disease: Consider Sj\u00f6gren Syndrome in the Differential Diagnosis","volume":"133","author":"Gonz\u00e1lez LA","year":"2020","unstructured":"Gonz\u00e1lez LA, Pantoja-Marquez AE, Johnson P. Diffuse Cystic Lung Disease: Consider Sj\u00f6gren Syndrome in the Differential Diagnosis. Am J Med. 2020, 133:e438-9. 10.1016\/j.amjmed.2020.01.028","journal-title":"Am J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.01.007","article-title":"Safety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis","volume":"163","author":"Gupta N","year":"2023","unstructured":"Gupta N, Zhang B, Zhou Y, et al.. Safety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis. Chest. 2023, 163:1144-55. 10.1016\/j.chest.2023.01.007","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1580690","article-title":"Diffuse Cystic Lung Diseases: Diagnostic Considerations","volume":"37","author":"Xu KF","year":"2016","unstructured":"Xu KF, Feng R, Cui H, et al.. Diffuse Cystic Lung Diseases: Diagnostic Considerations. Semin Respir Crit Care Med. 2016, 37:457-67. 10.1055\/s-0036-1580690","journal-title":"Semin Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-759BC","article-title":"Diffuse Cystic Lung Disease as the Presenting Manifestation of Sj\u00f6gren Syndrome","volume":"13","author":"Gupta N","year":"2016","unstructured":"Gupta N, Wikenheiser-Brokamp KA, Fischer A, McCormack FX. Diffuse Cystic Lung Disease as the Presenting Manifestation of Sj\u00f6gren Syndrome. Ann Am Thorac Soc. 2016, 13:371-5. 10.1513\/AnnalsATS.201511-759BC","journal-title":"Ann Am Thorac Soc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.676885","article-title":"Management of Sj\u00f6gren's Syndrome: Present Issues and Future Perspectives","volume":"8","author":"Vitali C","year":"2021","unstructured":"Vitali C, Minniti A, Pignataro F, Maglione W, Del Papa N. Management of Sj\u00f6gren's Syndrome: Present Issues and Future Perspectives. Front Med (Lausanne). 2021, 8:676885. 10.3389\/fmed.2021.676885","journal-title":"Front Med (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/392206-an-unusual-case-of-primary-sjgrens-syndrome-and-lymphangioleiomyomatosis-diagnosed-from-refractory-cough","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T08:04:48Z","timestamp":1755072288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/392206-an-unusual-case-of-primary-sjgrens-syndrome-and-lymphangioleiomyomatosis-diagnosed-from-refractory-cough"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.89956","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}